search
Back to results

INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer (INEXTREMO)

Primary Purpose

Colorectal Cancer

Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Laparoscopic right hemicolectomy for cancer
Sponsored by
Ospedale Misericordia e Dolce
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colorectal Cancer focused on measuring Colorectal cancer, Laparoscopic right hemicolectomy, Intracorporeal anastomosis

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria

  • Patients suitable for curative surgery 18-80 years old
  • ASA grade I-III
  • Histhopatological confirmed right only colon carcinoma.
  • Elective interventions
  • Laparoscopic surgery
  • Informed consent

Exclusion criteria

  • Informed consent refusal
  • Metastatic disease
  • Not right colon cancer
  • Non elective procedure
  • Open or converted operations

Sites / Locations

  • Misericordia e Dolce Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Intracorporeal anastomosis

Extracorporeal anastomosis

Arm Description

Laparoscopic right hemicolectomy for cancer. .For the IA group, colon, transverse mesocolon, ileum and terminal ileum mesentery will be resected intracorporeally through a 45 mm endoscopic linear stapler with vascular cartridge. Then, the linear stapler will inserted through two small enterotomies and a mechanical ileo-transverse, side-to-side isoperistaltic intracorporeal anastomosis performed using the vascular cartridge with six rows of closely placed staples. The enterotomies will be then closed using a double layered continuous intra corporeal manual suture with 3-0 Polyglactin 910. The mesenteric defects will be left open. The specimen will be placed in a protective plastic bag and then extracted through a Pfannestiel incision.

Laparoscopic right hemicolectomy for cancer. In the EA group, the bowel will be externalized by widening the incision of one of the trocars or by performing a mini-laparotomy at another location (subcostal, suprapubic) protected with a plastic sheet. The ileum and colon will be then resected through a 45 mm endoscopic linear stapler with vascular cartridge (staple height = 3.85 mm) and a side-to-side isoperistaltic mechanical anastomosis will be then performed using the same vascular cartridge. The enterotomies will be then closed using a double layered continuous manual suture using a 3-0 Polyglactin 910. In both groups, a drain will not routinely inserted.

Outcomes

Primary Outcome Measures

Overall surgical morbidity
Surgical morbidity rate defined as any diagnosed morbidity related to surgical technique (anastomotic leakage, anastomotic bleeding, wound infection, ileus) within 60 days from surgery.

Secondary Outcome Measures

Operative time
Minutes from skin incision to skin closure
Largest incision length
millimeters of skin incision
Numbers of node harvested
Numbers of node harvested
Intraoperative complicatons
Incidence and kind of intraoperative morbidity
Mortality
Incidence and kind of intraoperative morbidity
Non surgical site complications
Incidence and kind of medical morbidity (cardiovascular, respiratory, or metabolic events; nonsurgical infections; deep venous thrombosis; and pulmonary embolism)
Bowel movement
Defined as hours from surgery to peristalsis, assessement every 8 hours
First flatus
Defined as hours from surgery to first flatus
First stool canalization
Defined as hours from surgery to first stool canalization
Time to solid diet
Defined as hours from surgery to solid diet tolerance
Naso gastric tube reintroduction
Defined as rate of NGT reintroduction
Days of analgesic usage
Defined as number of days after interventions
Length of hospital stay
Defined as day from surgery to dismission plus eventual days of recovery after readmission
Readmission
Rate of readmission after home dimission

Full Information

First Posted
September 1, 2012
Last Updated
September 1, 2012
Sponsor
Ospedale Misericordia e Dolce
search

1. Study Identification

Unique Protocol Identification Number
NCT01679756
Brief Title
INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer
Acronym
INEXTREMO
Official Title
INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer: a Randomized Clinical Trial. (IN EXTREMO Study)
Study Type
Interventional

2. Study Status

Record Verification Date
September 2012
Overall Recruitment Status
Unknown status
Study Start Date
March 2013 (undefined)
Primary Completion Date
March 2014 (Anticipated)
Study Completion Date
June 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ospedale Misericordia e Dolce

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this systematic review is to compare intracorporeal (IA) versus extracorporeal anastomosis (EA) after laparoscopic right hemicolectomy for cancer.
Detailed Description
Background. Only a few retrospective publications comparing these anastomotic techniques and no randomized clinical trial has been performed. We conducted a meta-analysis of the existing non randomized comparative studies on the argument: the results suggest that the IA results in better postoperative recovery outcomes, such as shorter hospital stay, faster bowel movement recovery, faster first flatus, faster time to solid diet and lesser analgesic usage. Design: Two-armed, double-blinded, randomized, controlled study. The patients will be randomized into two groups: A. After laparoscopic right colectomy for cancer, anastomosis will be carried out intracorporeally (IA) B. After laparoscopic right colectomy for cancer, anastomosis will be carried out extracorporeally (EA) Primary endpoint: Surgical morbidity rate defined as any diagnosed morbidity related to surgical technique (anastomotic leakage, anastomotic bleeding, wound infection, ileus) within 60 days from surgery. Secondary endpoints: Intra-operative: operative time, largest incision length (mm), number of nodes harvested, intraoperative complications. Early postoperative: mortality, non-surgical site complications. Postoperative recovery: bowel movement, first flatus, time to solid diet, nasogastric tube (NGT) reintroduction, day of analgesic usage, length of stay, readmission. Randomization. The randomization will be obtained through a computer generated program (GraphPad Software, Inc, La Jolla, California, USA). The randomization, will be done before the beginning of the study and it will consist with an ordered series of numbers with a corresponding letter: A for intracorporeal anastomosis and B for extracorporeal anastomosis. This series of numbers will be kept in a central dedicated web database; after right colon cancer diagnosis, if the patient fulfills the inclusion criteria and signs the consent a number, progressive as in order of inclusion, will be assigned to him or her. The letter corresponding to the number, and hence the type of procedure to perform, will be notified to the operating surgeon, who will proceed accordingly. Blinding. A second surgeon team (different from the one who participate in the intervention), aware of the operative findings but not the management of the anastomosis, will then assume the care of the patient. Postoperative care and ability to be discharged from the hospital will be determined by the second surgical team. This second surgical team will be blinded to the kind of anastomosis. The primary operative team will be in every moment available for emergent consultation. Power Calculation. The reported prevalence of surgical morbidity after laparoscopic colectomy varies widely from 5-15%16-39, usually depending on the definition of complications and the type of resection performed. The most recent Cochrane review on the argument indicates a 8.6% of local morbidity (Wound infection, anastomotic insufficiency, postoperative ileus, postoperative bleeding)40. Therefore the number of patients required was based on the hope of improving the rate of surgical morbidity from 8.6% to 4.3%; considering a drop-out rate of 5%, 384 patients (192 in the IA group and 192 in the EA group) are necessary to ensure an 80% power with an alpha of 5%, when using a two-sided log-rank test. The statistical power sample calculation was carried out using PASS 2005 (Power Analysis and Sample Size, within the statistical package "NCSS 2004 and PASS 2005"). Sixty-four patients will be included by each of the six centers of the consortium. Only surgeons with at least 30 right colectomies performed with intracorporeal anastomosis will be allowed to recruit patients as first operator. Statistics. To evaluate significance of differences between the two groups, chi-squared and Fisher's exact test will be used as appropriated for categorical variables, and the non-parametric Mann-Whitney U-test for continuous variables. Significance level will be set at 5%. The statistical analysis will be carried out using the Statistical Package for the Social Sciences (SPSS version 13; SPSS Inc. Chicago, Illinois, USA). Monitoring. as commonly requested for Randomized Controlled Trials on patients, a strict control of outcomes has been planned during the study. Three experts in laparoscopic colorectal surgery will be designed as member of IN EXTREMO Trial Monitoring Committee. They would have access to the data during the whole course of the study and indicate cessation of the trial if one arm is providing manifestly inferior results.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
Colorectal cancer, Laparoscopic right hemicolectomy, Intracorporeal anastomosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
384 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intracorporeal anastomosis
Arm Type
Experimental
Arm Description
Laparoscopic right hemicolectomy for cancer. .For the IA group, colon, transverse mesocolon, ileum and terminal ileum mesentery will be resected intracorporeally through a 45 mm endoscopic linear stapler with vascular cartridge. Then, the linear stapler will inserted through two small enterotomies and a mechanical ileo-transverse, side-to-side isoperistaltic intracorporeal anastomosis performed using the vascular cartridge with six rows of closely placed staples. The enterotomies will be then closed using a double layered continuous intra corporeal manual suture with 3-0 Polyglactin 910. The mesenteric defects will be left open. The specimen will be placed in a protective plastic bag and then extracted through a Pfannestiel incision.
Arm Title
Extracorporeal anastomosis
Arm Type
Active Comparator
Arm Description
Laparoscopic right hemicolectomy for cancer. In the EA group, the bowel will be externalized by widening the incision of one of the trocars or by performing a mini-laparotomy at another location (subcostal, suprapubic) protected with a plastic sheet. The ileum and colon will be then resected through a 45 mm endoscopic linear stapler with vascular cartridge (staple height = 3.85 mm) and a side-to-side isoperistaltic mechanical anastomosis will be then performed using the same vascular cartridge. The enterotomies will be then closed using a double layered continuous manual suture using a 3-0 Polyglactin 910. In both groups, a drain will not routinely inserted.
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic right hemicolectomy for cancer
Intervention Description
After induction of anesthesia, a foley catheter and an NG tube will be inserted. All patients will have their NG tubes removed after the procedure. During the procedure patients will be placed in Trendelenburg position with 15 degrees of tilt and with a right side up (tilt to the left of 25 degrees). A Veres needle will be inserted and pneumoperitoneum induced and maintained at 12 mmHg for the entire duration of the procedure. Under direct vision, three 10-12mm trocars will be inserted in the left abdominal wall. The ileocolic vessels, the right colic vessels (when present), the right branch of the middle colic vessels and the right gastroepiploic vessels will be ligated intracorporeally at their origin using clips. Anastomosis are described in each arm description.
Primary Outcome Measure Information:
Title
Overall surgical morbidity
Description
Surgical morbidity rate defined as any diagnosed morbidity related to surgical technique (anastomotic leakage, anastomotic bleeding, wound infection, ileus) within 60 days from surgery.
Time Frame
60 days from surgery
Secondary Outcome Measure Information:
Title
Operative time
Description
Minutes from skin incision to skin closure
Time Frame
day of intervention
Title
Largest incision length
Description
millimeters of skin incision
Time Frame
day of intervention
Title
Numbers of node harvested
Description
Numbers of node harvested
Time Frame
day of intervention
Title
Intraoperative complicatons
Description
Incidence and kind of intraoperative morbidity
Time Frame
day of intervention
Title
Mortality
Description
Incidence and kind of intraoperative morbidity
Time Frame
60 days from surgery
Title
Non surgical site complications
Description
Incidence and kind of medical morbidity (cardiovascular, respiratory, or metabolic events; nonsurgical infections; deep venous thrombosis; and pulmonary embolism)
Time Frame
60 days from surgery
Title
Bowel movement
Description
Defined as hours from surgery to peristalsis, assessement every 8 hours
Time Frame
10 days from surgery
Title
First flatus
Description
Defined as hours from surgery to first flatus
Time Frame
10 days from surgery
Title
First stool canalization
Description
Defined as hours from surgery to first stool canalization
Time Frame
10 days from surgery
Title
Time to solid diet
Description
Defined as hours from surgery to solid diet tolerance
Time Frame
10 days from surgery
Title
Naso gastric tube reintroduction
Description
Defined as rate of NGT reintroduction
Time Frame
60 days from surgery
Title
Days of analgesic usage
Description
Defined as number of days after interventions
Time Frame
60 days from surgery
Title
Length of hospital stay
Description
Defined as day from surgery to dismission plus eventual days of recovery after readmission
Time Frame
60 days from surgery
Title
Readmission
Description
Rate of readmission after home dimission
Time Frame
60 day from intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria Patients suitable for curative surgery 18-80 years old ASA grade I-III Histhopatological confirmed right only colon carcinoma. Elective interventions Laparoscopic surgery Informed consent Exclusion criteria Informed consent refusal Metastatic disease Not right colon cancer Non elective procedure Open or converted operations
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Francesco Feroci, MD
Phone
+393398382381
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marco Scatizzi, MD
Organizational Affiliation
Misericordia e Dolce Hospital
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Francesco Feroci, MD
Organizational Affiliation
Misericordia e Dolce Hospital
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Stefano Cantafio, MD
Organizational Affiliation
Misericordia e Dolce Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Misericordia e Dolce Hospital
City
Prato
State/Province
Po
ZIP/Postal Code
59100
Country
Italy
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francesco Feroci, MD
Phone
+393398382381
Email
fferoci@yahoo.it
First Name & Middle Initial & Last Name & Degree
Elisa Lenzi, MD
First Name & Middle Initial & Last Name & Degree
Andrea Vannucchi, MD
First Name & Middle Initial & Last Name & Degree
Alessia Garzi, MD
First Name & Middle Initial & Last Name & Degree
Maddalena Baraghini, MD

12. IPD Sharing Statement

Citations:
PubMed Identifier
20703468
Citation
Scatizzi M, Kroning KC, Borrelli A, Andan G, Lenzi E, Feroci F. Extracorporeal versus intracorporeal anastomosis after laparoscopic right colectomy for cancer: a case-control study. World J Surg. 2010 Dec;34(12):2902-8. doi: 10.1007/s00268-010-0743-6.
Results Reference
background

Learn more about this trial

INtracorporeal Versus EXTracorpoREal anastoMOsis After Laparoscopic Right Colectomy for Cancer

We'll reach out to this number within 24 hrs